부산대학교 도서관

M. Heikkilä; K. Luoma; T. Mäkelä; T. Grönholm

Atmospheric Chemistry and Physics, Vol 24, Pp 8927-8941 (2024)

Michaela Feodoroff; Firas Hamdan; Gabriella Antignani; Sara Feola; Manlio Fusciello; Salvatore Russo; Jacopo Chiaro; Katja Välimäki; Teijo Pellinen; Rui M. Branca; Janne Lehtiö; Federica D´alessio; Paolo Bottega; Virpi Stigzelius; Janita Sandberg; Jonna Clancy; Jukka Partanen; Minna Malmstedt; Antti Rannikko; Vilja Pietiäinen; Mikaela Grönholm; Vincenzo Cerullo

OncoImmunology, Vol 13, Iss 1 (2024)

Jacopo Chiaro; Gabriella Antignani; Sara Feola; Michaela Feodoroff; Beatriz Martins; Hanne Cojoc; Salvatore Russo; Manlio Fusciello; Firas Hamdan; Valentina Ferrari; Daniele Ciampi; Ilkka Ilonen; Jari Räsänen; Mikko Mäyränpää; Jukka Partanen; Satu Koskela; Jarno Honkanen; Jussi Halonen; Lukasz Kuryk; Maria Rescigno; Mikaela Grönholm; Rui M. Branca; Janne Lehtiö; Vincenzo Cerullo

Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)

Hamdan F; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Gandolfi S; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; D'Alessio F; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Giannoula Y; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Kolikova J; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Applied Tumor Genomics Research, Research Program Unit, University of Helsinki, Helsinki, Finland.; Fusciello M; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Zaghen E; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Napolano A; Department of Molecular Medicine and Medical Biotechnology, Naples University 'Federico II', S. Pansini 5, Naples, Italy.; Department of Molecular Medicine and Medical Biotechnology and CEINGE, Naples University Federico II, Naples, Italy.; Russo S; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Izci O; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Bottega P; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Chiaro J; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Alanen KM; Biochemistry/Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Antignani G; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Feodoroff M; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Stigzelius V; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; Cell Therapy Safety, Clinical and Pharmacological Safety Sciences, AstraZeneca R&D, Pepparedsleden 1, Mölndal, Sweden.; Sakalauskaite M; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Sandberg J; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Nieminen AI; Helsinki Metabolomics Center, Stem Cell and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Zambrano N; Department of Molecular Medicine and Medical Biotechnology, Naples University 'Federico II', S. Pansini 5, Naples, Italy.; Department of Molecular Medicine and Medical Biotechnology and CEINGE, Naples University Federico II, Naples, Italy.; Eriksson O; Biochemistry/Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Mustjoki S; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Seppälä TT; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Applied Tumor Genomics Research, Research Program Unit, University of Helsinki, Helsinki, Finland.; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.; Department of Gastrointestinal Surgery, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.; Grönholm M; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Cerullo V; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland. vincenzo.cerullo@helsinki.fi.; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, Helsinki, Finland. vincenzo.cerullo@helsinki.fi.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, Haartmaninkatu 8, University of Helsinki, Helsinki, Finland. vincenzo.cerullo@helsinki.fi.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. vincenzo.cerullo@helsinki.fi.; Department of Molecular Medicine and Medical Biotechnology and CEINGE, Naples University Federico II, Naples, Italy. vincenzo.cerullo@helsinki.fi.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

P. Kiuru; M. Palviainen; A. Marchionne; T. Grönholm; M. Raivonen; L. Kohl; A. Laurén

Biogeosciences, Vol 19, Pp 5041-5058 (2022)

Sokhi, Ranjeet S.; Moussiopoulos, Nicolas; Baklanov, Alexander; Bartzis, John; Coll, Isabelle; Finardi, Sandro; Friedrich, Rainer; Geels, Camilla; Grönholm, Tiia; Halenka, Tomas; Ketzel, Matthias; Maragkidou, Androniki; Matthias, Volker; Moldanova, Jana; Ntziachristos, Leonidas; Schäfer, Klaus; Suppan, Peter; Tsegas, George; Carmichael, Greg; Franco, Vicente; Hanna, Steve; Jalkanen, Jukka-Pekka; Velders, Guus J. M.; Kukkonen, Jaakko

Atmospheric Chemistry And Physics. 22(7):4615-4703

Kaustio, Meri; Szymanska, Monika; Li, Weiwei; Braathen, Ragnhild; Campbell, Tessa M.; Haugen, Frida L.; Dahal-Koirala, Shiva; Silventoinen, Kristiina; Nurmi, Katariina; Dinius, Matas; Nowlan, Kirsten; Hetemäki, Iivo; Chen, Pu; Mamia, Katariina; Seppänen, Mikko R.J.; Grönholm, Juha; Kekäläinen, Eliisa; Haapaniemi, Emma M.; Aalto, Kristiina; Martelius, Timi

Journal of Allergy & Clinical Immunology. Oct2025, Vol. 156 Issue 4, p1024-1037. 14p.

M. Karl; L. Pirjola; T. Grönholm; M. Kurppa; S. Anand; X. Zhang; A. Held; R. Sander; M. Dal Maso; D. Topping; S. Jiang; L. Kangas; J. Kukkonen

Geoscientific Model Development, Vol 15, Pp 3969-4026 (2022)

P. Kiuru; M. Palviainen; T. Grönholm; M. Raivonen; L. Kohl; V. Gauci; I. Urzainki; A. Laurén

Biogeosciences, Vol 19, Pp 1959-1977 (2022)

Russo S; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.; TRIMM, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; GeneCellNano flagship, University of Helsinki, Helsinki, Finland.; Giannoula Y; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.; TRIMM, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; GeneCellNano flagship, University of Helsinki, Helsinki, Finland.; Feola S; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Cerioni J; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Hamdan F; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.; TRIMM, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; GeneCellNano flagship, University of Helsinki, Helsinki, Finland.; Chiaro J; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.; TRIMM, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; GeneCellNano flagship, University of Helsinki, Helsinki, Finland.; Ha Dang AT; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Bottega P; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.; TRIMM, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; GeneCellNano flagship, University of Helsinki, Helsinki, Finland.; Feodoroff M; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.; TRIMM, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; GeneCellNano flagship, University of Helsinki, Helsinki, Finland.; Fusciello M; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; GeneCellNano flagship, University of Helsinki, Helsinki, Finland.; Stigzelius V; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Clinical and Pharmacological Safety Sciences, AstraZeneca R&D, Mölndal, Sweden.; D'Amico C; Department of Bioproducts and Biosystems, Aalto University, Helsinki, Finland.; Caiazza C; University of Naples Federico II, Naples, Italy.; Antignani G; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; GeneCellNano flagship, University of Helsinki, Helsinki, Finland.; D'Alessio F; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Sakalauskaite M; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.; TRIMM, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Petryk J; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Bell J; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Ilkow C; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Grönholm M; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.; TRIMM, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; GeneCellNano flagship, University of Helsinki, Helsinki, Finland.; Cerullo V; Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki Faculty of Pharmacy, Helsinki, Finland vincenzo.cerullo@helsinki.fi.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.; TRIMM, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; GeneCellNano flagship, University of Helsinki, Helsinki, Finland.; University of Naples Federico II, Naples, Italy.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Van Praagh, M.; Johansson, M.; Fagerqvist, J.; Grönholm, R.; Hansson, N.; Svensson, H.

Waste Management: international journal of integrated waste management, science and technology. 79:428-434

Koivunen E; Programme in Molecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.; Madhavan S; Programme in Molecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.; Bermudez Garrido L; Programme in Molecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.; Grönholm M; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Kaprio T; Programme in Translational Cancer Medicine, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Haglund C; Programme in Translational Cancer Medicine, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Andersson LC; Department of Pathology. Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Gahmberg CG; Programme in Molecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland carl.gahmberg@helsinki.fi.

Publisher: Life Science Alliance, LLC Country of Publication: United States NLM ID: 101728869 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2575-1077 (Electronic) Linking ISSN: 25751077 NLM ISO Abbreviation: Life Sci Alliance Subsets: MEDLINE

Outi M. Hirvonen; Riikka-Leena Leskelä; Lotta Grönholm; Olli Haltia; Samuli Voltti; Kristiina Tyynelä-Korhonen; Eeva K. Rahko; Juho T. Lehto; Tiina Saarto

BMC Palliative Care, Vol 19, Iss 1, Pp 1-9 (2020)

Laitila, J.; Hanif, M.; Sarparanta, J.; Lehtonen, J.; Khattab, A.; Grönholm, M.; Wallgren-Pettersson, C.; Pelin, K.

Neuromuscular Disorders. 30:S68-S69

Bottega P; Department of Pharmaceutical Biosciences, University of Helsinki, Faculty of Pharmacy ImmunoViroTherapy Lab, Drug Research Program, Viikinkaari 5E, 00790 Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Fabianinkatu 33, 00710 Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, 00014 Helsinki, Finland.; Fusciello M; Department of Pharmaceutical Biosciences, University of Helsinki, Faculty of Pharmacy ImmunoViroTherapy Lab, Drug Research Program, Viikinkaari 5E, 00790 Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Fabianinkatu 33, 00710 Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, 00014 Helsinki, Finland.; Hamdan F; Department of Pharmaceutical Biosciences, University of Helsinki, Faculty of Pharmacy ImmunoViroTherapy Lab, Drug Research Program, Viikinkaari 5E, 00790 Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Fabianinkatu 33, 00710 Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, 00014 Helsinki, Finland.; Chiaro J; Department of Pharmaceutical Biosciences, University of Helsinki, Faculty of Pharmacy ImmunoViroTherapy Lab, Drug Research Program, Viikinkaari 5E, 00790 Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Fabianinkatu 33, 00710 Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, 00014 Helsinki, Finland.; Russo S; Department of Pharmaceutical Biosciences, University of Helsinki, Faculty of Pharmacy ImmunoViroTherapy Lab, Drug Research Program, Viikinkaari 5E, 00790 Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Fabianinkatu 33, 00710 Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, 00014 Helsinki, Finland.; D'Alessio F; Department of Pharmaceutical Biosciences, University of Helsinki, Faculty of Pharmacy ImmunoViroTherapy Lab, Drug Research Program, Viikinkaari 5E, 00790 Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Fabianinkatu 33, 00710 Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, 00014 Helsinki, Finland.; Grönholm M; Department of Pharmaceutical Biosciences, University of Helsinki, Faculty of Pharmacy ImmunoViroTherapy Lab, Drug Research Program, Viikinkaari 5E, 00790 Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Fabianinkatu 33, 00710 Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, 00014 Helsinki, Finland.; Cerullo V; Department of Pharmaceutical Biosciences, University of Helsinki, Faculty of Pharmacy ImmunoViroTherapy Lab, Drug Research Program, Viikinkaari 5E, 00790 Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Fabianinkatu 33, 00710 Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, 00014 Helsinki, Finland.; Department of Molecular Medicine and Medical Biotechnology and CEINGE, Naples University Federico II, 80131 Naples, Italy.

Publisher: Cell Press Country of Publication: United States NLM ID: 101624857 Publication Model: eCollection Cited Medium: Print ISSN: 2329-0501 (Print) Linking ISSN: 23290501 NLM ISO Abbreviation: Mol Ther Methods Clin Dev Subsets: PubMed not MEDLINE

Kukkonen, J.; Fridell, Erik, 1963; Jalkanen, J. P.; Moldanova, Jana; Ntziachristos, L.; Grigoriadis, A.; Barmpas, F.; Tsegas, G.; Maragkidou, A.; Sofiev, M.; Grönholm, T.; Majamäki, E.; Borken-Kleefeld, J.; Sokhi, R.S.; Tiwari, P. R.; Ozdemir, U. A.; Zervakis, V.; Krasakopoulou, E.; Hassellöv, Ida-Maja, 1974; Ytreberg, Erik, 1980; Williams, I.; Hudson, M.; Zapata-Restrepo, L.; Hole, L. R.; Aghito, M.; Breivik, Øyvind; Petrovic, M.; Rodriguez-Mozaz, S.; Ktoris, A.; Neophytou, M.; Monteiro, A.; Russo, M. A.; Oikonomou, F.; Arampatzi, P.; Gondikas, A.; Marcomini, A.; Giubilato, E.; Calgaro, L.; Jaakkola, J. J.K.; Kiihamäki, S. P.; Aittamaa, R.; Broström, Göran; Hassellöv, Martin, 1970; Tamminen, J.; Nicolas, F.; Kaitaranta, J.; Granberg, Maria E.; Magnusson, Kerstin, 1957

Evaluation, control and Mitigation of the EnviRonmental impacts of shippinG Emissions (EMERGE) 38th International Technical Meeting on Air Pollution Modeling and its Application, ITM 2021, Barcelona, Spain Springer Proceedings in Complexity. :329-336

A. Virkkula; J. Levula; T. Pohja; P. P. Aalto; P. Keronen; S. Schobesberger; C. B. Clements; L. Pirjola; A.-J. Kieloaho; L. Kulmala; H. Aaltonen; J. Patokoski; J. Pumpanen; J. Rinne; T. Ruuskanen; M. Pihlatie; H. E. Manninen; V. Aaltonen; H. Junninen; T. Petäjä; J. Backman; M. Dal Maso; T. Nieminen; T. Olsson; T. Grönholm; J. Aalto; T. H. Virtanen; M. Kajos; V.-M. Kerminen; D. M. Schultz; J. Kukkonen; M. Sofiev; G. De Leeuw; J. Bäck; P. Hari; M. Kulmala

Atmospheric Chemistry and Physics, Vol 14, Iss 9, Pp 4473-4502 (2014)

Gurung, D.; Neupane, M.; Bhattarai, K.; Acharya, B.; Gautam, N. C.; Gautam, K.; Koirala, S.; Marahatta, K.; Gurung, P.; Khadka, K. B.; Kohrt, B. A.; Thornicroft, G.; Gronholm, P. C.

EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES; DEC 13 2023, 32 21p.

Sagath, L.; Blondelle, J.; Laitila, J.; Lehtokari, V.; Kiiski, K.; Grönholm, M.; Wallgren-Pettersson, C.; Lange, S.; Pelin, K.

Neuromuscular Disorders. 30:S69-S69

Mokbel, N; Ilkovski, B; Kreissl, M; Memo, M; Jeffries, CM; Marttila, M; Lehtokari, V-L; Lemola, E; Grönholm, M; Yang, N; Menard, D; Marcorelles, P; Echaniz-Laguna, A; Reimann, J; Vainzof, M; Monnier, N; Ravenscroft, G; McNamara, E; Nowak, KJ; Laing, NG; Wallgren-Pettersson, C; Trewhella, J; Marston, S; Ottenheijm, C; North, KN; Clarke, NF

Mokbel, N, Ilkovski, B, Kreissl, M, Memo, M, Jeffries, C M, Marttila, M, Lehtokari, V L, Lemola, E, Gronholm, M, Yang, N, Menard, D, Marcorelles, P, Echaniz-Laguna, A, Reimann, J, Vainzof, M, Monnier, N, Ravenscroft, G, McNamara, E, Nowak, K J, Laing, N G, Wallgren-Pettersson, C, Trewhella, J, Marston, S, Ottenheijm, C A C, North, K N & Clarke, N F 2013, 'K7del is a common TPM2 gene mutation associated with nemaline myopathy and raised myofibre calcium sensitivity', Brain, vol. 136, pp. 494-507. https://doi.org/10.1093/brain/aws348